Senior Scientist I, Clinical Trial Safety (fix term/secondment)
AstraZeneca
About this role
A Senior Scientist I, Clinical Trial Safety at AstraZeneca is a fixed-term/secondment role based in Warsaw within the Trial Safety Review Center (TRISARC) in Research & Development, until 31 December 2026. The position supports the integrity and oversight of clinical trial safety data and works closely with cross-functional study teams to uphold data quality and regulatory standards. The role contributes to study start-up activities and reporting within a global clinical development environment.
Skills
Qualifications
About AstraZeneca
astrazeneca.comDigital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
About AstraZeneca
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AstraZeneca.
Salary
$123k – $167k
per year
More jobs at AstraZeneca
Similar Jobs
Clinical Trial Safety Scientist (FSP - Permanent Home Based)
IQVIA
Clinical Trial Research Scientist
Labelbox
Clinical Scientist Associate Director
Amgen
Clinical Scientist Associate Director (x3)
Amgen
Clinical Instructor/Clinical Assistant Professor/Clinical Associate Professor/Clinical Professor/Teaching Assistant Professor/Teaching Associate Professor/Teaching Professor/Research Assistant Professor/Research Associate Professor/Research Professor
Trinity College
Clinical Scientist Associate Director – Late Development, Obesity Therapeutic Area
Amgen